GNRH1 and prostate cancer: In addition, the overlapped targets of miR-196a were enriched in several pathways including glioma, focal adhesion, ECM–receptor interaction, gap junction, prostate cancer, GnRH signaling pathway, melanogenesis, and insulin signaling pathway (Table 3).